BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qin G, Zhang Y, Yao SK. Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance. World J Clin Cases 2020; 8(9): 1632-1641 [PMID: 32432141 DOI: 10.12998/wjcc.v8.i9.1632]
URL: https://www.wjgnet.com/1007-9327/full/v8/i9/1632.htm
Number Citing Articles
1
Hyun Deok Noh, Min Jeong Kim, Im Hak Cho, So Yeon Kim. Review on the Objective Effect and Mechanism Studies of Herbal Medicine, Acupuncture and Moxibustion Treatment for Irritable Bowel Syndrome PatientsJournal of Physiology & Pathology in Korean Medicine 2021; 35(5): 199 doi: 10.15188/kjopp.2021.10.35.5.199
2
Zhichao Hu, Meixuan Li, Liang Yao, Yinshu Wang, Enkang Wang, Jianye Yuan, Fengyun Wang, Kehu Yang, Zhaoxiang Bian, Linda L. D. Zhong. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysisBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-020-01593-5
3
Huilian Li, Cuilan An. Exploring the role of neurogenic pathway-linked cholecystokinin release in remote preconditioning-induced cardioprotectionActa Cirúrgica Brasileira 2020; 35(9) doi: 10.1590/s0102-865020200090000006
4
Peter Paine. Review article: current and future treatment approaches for pain in IBSAlimentary Pharmacology & Therapeutics 2021; 54(S1) doi: 10.1111/apt.16550